NZ Study Shows Obesity Counters Aromatase Inhibitors
This article was originally published in PharmAsia News
Executive Summary
Aromatase inhibitor drugs have been shown effective in treating breast cancer in postmenopausal women, but a New Zealand study says obesity appears to counter their beneficial effects.